Patent details

Basic Information

Publication number:

EP2952177

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151737665

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS COMPRISING SPHINGOSINE 1 PHOSPHATE (S1P) RECEPTOR MODULATORS

French Title of Invention:

COMPOSITIONS COMPRENANT DES MODULATEURS DE RÉCEPTEUR DE SPHINGOSINE 1 (S1P) PHOSPHATE

German Title of Invention:

ZUSAMMENSETZUNG MIT SPHINGOSIN-1-PHOSPHAT (S1P)-REZEPTORMODULATOREN

SPC Number:

Dates

Filing date:

09/10/2008

Grant date:

20/01/2021

EP Publication Date:

09/12/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/01/2021

EP B1 Publication Date:

20/01/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/10/2021

Expiration date:

09/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/01/2021

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

RUEGGER, Colleen

Address:

Switzerland (CH)

2

Name:

AMBUEHL, Michael

Address:

Switzerland (CH)

Priority

Priority Number:

979482 P

Priority Date:

12/10/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/20; A61K 9/70; A61K 31/133; A61K 31/137;

Publication

European Patent Bulletin

1

Issue number:

202103

Publication date:

20/01/2021

Description:

Grant (B1)

2

Issue number:

202408

Publication date:

21/02/2024

Description:

Termination of the opposition

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages